Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A 2026 review in the American Journal of Sports Medicine emphasizes that despite popularity, "significant research regarding the safety and efficacy of these therapeutic methods is required before definitive recommendations can be made to patients." Only a single human case series exists for BPC-157 (for knee pain), with significant methodological flaws and no controls
So 0.1 mL is 10 units, 0.5 mL is 50 units, and 1 mL is 100 units
Nerve damage, neurological impairment, and digestive system damage are late-stage deficiency signs
Most of the available data on the drugs safety come from preclinical investigations
(PubMed) Hathcock JN, Shao A
Schedule shape Typical published research planning splits a daily total into one or two doses
US$ 28.19
US$ 28.52
US$ 24.28
US$ 25.47
US$ 25.40
